日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting super-enhancer-driven SKIL transcription by CDK7 inhibitor THZ1 to suppress gastric cancer progression

利用 CDK7 抑制剂 THZ1 靶向超级增强子驱动的 SKIL 转录以抑制胃癌进展

Lan, Bingxue; Zhou, Tianli; Pan, Li; Cui, Miaomiao; Tan, Qiqi; Pu, Tingwei; Ran, Lianhui; Wei, Sixi; Zhu, Xu; Huang, Hai

CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer

CDK7靶向疗法可有效干扰头颈癌的细胞周期进程和致癌信号传导。

Otero-Rosales, María; Álvarez-González, Miguel; Pazos, Irene; de Luxán-Delgado, Beatriz; Del Marro, Sonia; Pozo-Agundo, Esperanza; Rodríguez-Santamaría, Mar; López-Fernández, Ana; Corte-Torres, Daniela; Granda-Díaz, Rocío; Álvarez-Teijeiro, Saúl; Fernández-Vega, Iván; Lorz, Corina; García-Escudero, Ramón; Rodrigo, Juan P; Tzelepis, Konstantinos; Vassiliou, George; Ferrer, Irene; Álvarez-Fernández, Mónica; García-Pedrero, Juana María; Hermida-Prado, Francisco

De-JAKing resistance with CDK7 inhibitors in post-MPN sAML

在MPN后继发性急性髓系白血病(sAML)中,使用CDK7抑制剂克服JAK耐药性

Castilla, Lucio H

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

作者更正:CDK7抑制剂samuraciclib I期研究中晚期乳腺癌患者的剂量递增和扩展队列

Coombes, R C; Howell, Sacha; Lord, Simon R; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G

Dual targeting of CDK4/6 and CDK7 augments tumor response and antitumor immunity in breast cancer models

双重靶向 CDK4/6 和 CDK7 可增强乳腺癌模型中的肿瘤反应和抗肿瘤免疫力

Sungsoo Kim ,Eugene Son ,Ha-Ram Park ,Minah Kim ,Hee Won Yang

CDK7-CDK11 axis in spliceosome regulation and pre-mRNA splicing.

CDK7-CDK11轴在剪接体调控和前体mRNA剪接中的作用。

Rájecký Michal, Gajdušková Pavla, Maník Peter, Hluchý Milan, Hegedűsová Eva, Kryštofová Karolína, Potěšil David, Martinková Petra, Slabá Zuzana, Khirsariya Prashant, Šebesta Marek, Paruch Kamil, Friedel Caroline C, Zdráhal Zbyněk, Blazek Dalibor

Erratum for the Research Article "TFIIH kinase CDK7 drives cell proliferation through a common core transcription factor network" by T. Jones et al

T. Jones 等人的研究论文“TFIIH 激酶 CDK7 通过共同的核心转录因子网络驱动细胞增殖”的勘误

Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression

赖氨酸特异性去甲基化酶1通过CDK7磷酸化调控关键的OSCC癌前病变诱导因子STAT3,从而在肿瘤发生发展和免疫抑制过程中发挥作用。

Amit Kumar Chakraborty # ,Rajnikant Dilip Raut # ,Kisa Iqbal ,Chumki Choudhury ,Thabet Alhousami ,Sami Chogle ,Alexa S Acosta ,Lana Fagman ,Kelly Deabold ,Marilia Takada ,Bikash Sahay ,Vikas Kumar ,Manish V Bais

Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells.

癌细胞中保守残基的获得性突变导致对 CDK7 抑制剂产生耐药性。

FAIM modulates HCC progression via enhancing HMGA1 interaction with CDK7 and promoting its phosphorylation level.

FAIM 通过增强 HMGA1 与 CDK7 的相互作用并促进其磷酸化水平来调节 HCC 的进展。

Li Yuan, Liu Wenna, Fan Xushen, Wu Xinyi, Cao Mingbo, Li Xiuling, Wurita Amin, Sun Suofeng